Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

GLP-1 medications have become popular for weight loss, and for good reason—they can help regulate appetite and support weight ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

as prior studies have reported GLP-1 receptor agonist discontinuation rates of up to 81%, Emanuel's group wrote. They added that the links between weight loss and discontinuation and between ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.